04/17/2025
6:41 AM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2025
7:27 AM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2025
5:56 AM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/24/2025
5:05 AM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/17/2025
11:15 PM | Clearmind Medicine (Filer)
| Form EFFECT | |
02/18/2025
11:15 PM | Clearmind Medicine (Filer)
| Form EFFECT | |
02/14/2025
12:27 PM | Clearmind Medicine (Subject)
Iroquois Capital Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/04/2025
3:01 PM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/22/2025
3:30 PM | Clearmind Medicine (Filer)
| Form POS AM | |
01/07/2025
3:00 PM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/09/2024
4:12 PM | Clearmind Medicine (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/06/2024
4:00 PM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024
11:15 PM | Clearmind Medicine (Filer)
| Form EFFECT | |
09/24/2024
3:30 PM | Clearmind Medicine (Filer)
| Form POS AM | |
09/12/2024
3:01 PM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/29/2024
3:30 PM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/20/2024
3:15 PM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/30/2024
11:15 PM | Clearmind Medicine (Filer)
| Form EFFECT | |
07/23/2024
3:15 PM | Clearmind Medicine (Filer)
| Form POS AM | |
06/13/2024
3:01 PM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/13/2024
3:01 PM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024
3:16 PM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Buy CMND Stock Free CMND Stock Alerts